# This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men

> **NCT03307252** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 45 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Furosemide
- **DRUG:** Metformin
- **DRUG:** Rosuvastatin
- **DRUG:** Verapamil
- **DRUG:** Rifampin
- **DRUG:** Cimetidine
- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT03307252
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-25
- **Primary completion:** 2018-05-02
- **Final completion:** 2018-05-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03307252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03307252, "This Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy Men". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03307252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*